This inventor holds 0 USPTO granted patents, plus 4 CIPO patents.
Title: Gregory Ian Vladimer: Innovator in Cellular Medicine
Introduction
Gregory Ian Vladimer is a notable inventor based in Austria. He has made significant contributions to the field of cellular medicine, particularly in the development of methods involving peripheral blood mononuclear cells (PBMCs) and bone-marrow cells. His work focuses on innovative approaches to disease diagnosis and therapeutic response evaluation.
Latest Patents
Gregory Ian Vladimer holds a patent titled "Monolayer Of Pbmcs Or Bone-Marrow Cells And Uses Thereof." This invention relates to the culture of PBMC and bone-marrow cell monolayers. It also encompasses methods for screening therapeutic responses and diagnosing diseases in donors of these cells. Although he currently has 0 patents, his research has the potential to impact therapeutic strategies significantly.
Career Highlights
Vladimer is associated with the CEMM Forschungszentrum für Molekulare Medizin GmbH, where he engages in cutting-edge research. His work is pivotal in advancing the understanding of cellular responses to treatments, which can lead to improved patient outcomes.
Collaborations
He collaborates with esteemed colleagues such as Berend Snijder and Giulio Superti-Furga. These partnerships enhance the research environment and foster innovation in cellular medicine.
Conclusion
Gregory Ian Vladimer is a dedicated inventor whose work in cellular medicine holds promise for future advancements in disease diagnosis and treatment. His contributions, although currently limited in patent count, reflect a commitment to improving healthcare through innovative research.